Effect of postextubation high-flow nasal cannula therapy on lung recruitment and overdistension in high-risk patient

Critical Care : the Official Journal of the Critical Care Forum
Rui ZhangZhanqi Zhao

Abstract

Postextubation high-flow nasal cannula (HFNC) is used as a support therapy in high-risk patients in ICU. This study aimed to determine the effects of HFNC therapy on lung recruitment and overdistension assessed by electrical impedance tomography (EIT). Twenty-four patients who received HFNC within 24 h after extubation were prospectively enrolled in this study. EIT was used to monitor regional lung ventilation distributions at baseline (conventional oxygen therapy) and three flow rate levels of HFNC therapy (20, 40, and 60 L/min). Change of end-expiratory lung impedance (ΔEELI), regional recruitment (recruited-pixels) and overdistension (overdistended-pixels), and lung strain change were determined by EIT. EIT images were equally divided into four ventral-to-dorsal horizontal regions of interest (ROIs 1, 2, 3, and 4). "Overdistension-by HFNC" due to HFNC is defined as an increase of overdistened-pixels > 10 than baseline. Patients were divided into two groups: (1) high potential of recruitment (HPR), recruited-pixels > 10 pixels at 60 L/min than baseline, and (2) low potential of recruitment (LPR), recruited-pixels < 10 pixels at 60 L/min than baseline. When the flow rate gradually increased from baseline to 60 L/min, a signifi...Continue Reading

References

May 20, 2006·Biometrical Journal. Biometrische Zeitschrift·Anuradha Roy
Oct 14, 2006·American Journal of Respiratory and Critical Care Medicine·Pier Paolo TerragniV Marco Ranieri
Jan 25, 2011·American Journal of Respiratory and Critical Care Medicine·Giacomo BellaniAntonio Pesenti
Apr 19, 2011·Respiratory Care·Rachael L ParkeShay P McGuinness
Nov 24, 2011·Intensive Care Medicine·Adrián González-LópezGuillermo M Albaiceta
May 1, 2012·Anesthesia and Analgesia·Alysson Roncally CarvalhoAntonio Giannella-Neto
Nov 7, 2012·Respiration; International Review of Thoracic Diseases·Jens BräunlichHubert Wirtz
Dec 18, 2013·American Journal of Respiratory and Critical Care Medicine·Tommaso MauriAntonio Pesenti
Jul 9, 2014·American Journal of Respiratory and Critical Care Medicine·Salvatore Maurizio MaggioreMassimo Antonelli
May 20, 2015·JAMA : the Journal of the American Medical Association·François StéphanUNKNOWN BiPOP Study Group
May 20, 2015·The New England Journal of Medicine·Jean-Pierre FratUNKNOWN REVA Network
Jun 17, 2015·Intensive Care Medicine·Alexandre Demoule, Jordi Rello
Mar 16, 2016·JAMA : the Journal of the American Medical Association·Gonzalo HernándezRafael Fernández
May 5, 2016·Critical Care : the Official Journal of the Critical Care Forum·Songqiao LiuZhanqi Zhao
Sep 23, 2016·Critical Care : the Official Journal of the Critical Care Forum·Eirini KostakouLuigi Camporota
Dec 21, 2016·American Journal of Respiratory and Critical Care Medicine·Tommaso MauriAntonio Pesenti
Jul 14, 2017·Critical Care : the Official Journal of the Critical Care Forum·Luciano GattinoniMichael Quintel
Feb 22, 2018·American Journal of Respiratory and Critical Care Medicine·Hodane YonisClaude Guérin
Jul 2, 2018·Intensive Care Medicine·M PiastraG Conti
Dec 24, 2018·American Journal of Respiratory and Critical Care Medicine·Oriol RocaJean-Damien Ricard

❮ Previous
Next ❯

Software Mentioned

GraphPad
SPSS
Prism
GLMRM

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.